Wetzel Investment Advisors, Inc. Astrazeneca PLC Transaction History
Wetzel Investment Advisors, Inc.
- $174 Million
- Q2 2024
A detailed history of Wetzel Investment Advisors, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Wetzel Investment Advisors, Inc. holds 109 shares of AZN stock, worth $9,054. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109
Previous 319
65.83%
Holding current value
$9,054
Previous $21,000
61.9%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.39 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.54 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.37 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.05 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.46 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $257B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...